Peroral  ||| S:0 E:8 ||| NNP
Endoscopic  ||| S:8 E:19 ||| NNP
Myotomy  ||| S:19 E:27 ||| NNP
for  ||| S:27 E:31 ||| IN
Treating  ||| S:31 E:40 ||| NNP
Achalasia  ||| S:40 E:50 ||| NNP
and  ||| S:50 E:54 ||| CC
Esophageal  ||| S:54 E:65 ||| NNP
Motility  ||| S:65 E:74 ||| NNP
Disorders  ||| S:74 E:84 ||| NNP
Peroral  ||| S:84 E:92 ||| NNP
endoscopic  ||| S:92 E:103 ||| FW
myotomy  ||| S:103 E:111 ||| FW
( ||| S:111 E:112 ||| -LRB-
POEM ||| S:112 E:116 ||| NNP
)  ||| S:116 E:118 ||| -RRB-
is  ||| S:118 E:121 ||| VBZ
the  ||| S:121 E:125 ||| DT
application  ||| S:125 E:137 ||| NN
of  ||| S:137 E:140 ||| IN
esophageal  ||| S:140 E:151 ||| JJ
myotomy  ||| S:151 E:159 ||| NN
to  ||| S:159 E:162 ||| TO
the  ||| S:162 E:166 ||| DT
concept  ||| S:166 E:174 ||| NN
of  ||| S:174 E:177 ||| IN
natural  ||| S:177 E:185 ||| JJ
orifice  ||| S:185 E:193 ||| JJ
transluminal  ||| S:193 E:206 ||| JJ
surgery  ||| S:206 E:214 ||| NN
( ||| S:214 E:215 ||| -LRB-
NOTES ||| S:215 E:220 ||| NNP
)  ||| S:220 E:222 ||| -RRB-
by  ||| S:222 E:225 ||| IN
utilizing  ||| S:225 E:235 ||| VBG
a  ||| S:235 E:237 ||| DT
submucosal  ||| S:237 E:248 ||| JJ
tunneling  ||| S:248 E:258 ||| JJ
method ||| S:258 E:264 ||| NN
.  ||| S:264 E:266 ||| .
Since  ||| S:266 E:272 ||| IN
the  ||| S:272 E:276 ||| DT
first  ||| S:276 E:282 ||| JJ
case  ||| S:282 E:287 ||| NN
of  ||| S:287 E:290 ||| IN
POEM  ||| S:290 E:295 ||| NNP
was  ||| S:295 E:299 ||| VBD
performed  ||| S:299 E:309 ||| VBN
for  ||| S:309 E:313 ||| IN
treating  ||| S:313 E:322 ||| VBG
achalasia  ||| S:322 E:332 ||| NN
in  ||| S:332 E:335 ||| IN
Japan  ||| S:335 E:341 ||| NNP
in  ||| S:341 E:344 ||| IN
2008 ||| S:344 E:348 ||| CD
,  ||| S:348 E:350 ||| ,
this  ||| S:350 E:355 ||| DT
procedure  ||| S:355 E:365 ||| NN
is  ||| S:365 E:368 ||| VBZ
being  ||| S:368 E:374 ||| VBG
more  ||| S:374 E:379 ||| RBR
widely  ||| S:379 E:386 ||| RB
used  ||| S:386 E:391 ||| VBN
by  ||| S:391 E:394 ||| IN
many  ||| S:394 E:399 ||| JJ
skillful  ||| S:399 E:408 ||| NNS
endosopists  ||| S:408 E:420 ||| VBP
all  ||| S:420 E:424 ||| RB
over  ||| S:424 E:429 ||| IN
the  ||| S:429 E:433 ||| DT
world ||| S:433 E:438 ||| NN
.  ||| S:438 E:440 ||| .
Currently ||| S:440 E:449 ||| RB
,  ||| S:449 E:451 ||| ,
POEM  ||| S:451 E:456 ||| NNP
is  ||| S:456 E:459 ||| VBZ
a  ||| S:459 E:461 ||| DT
spotlighted ||| S:461 E:472 ||| NN
,  ||| S:472 E:474 ||| ,
emerging  ||| S:474 E:483 ||| VBG
treatment  ||| S:483 E:493 ||| NN
option  ||| S:493 E:500 ||| NN
for  ||| S:500 E:504 ||| IN
achalasia ||| S:504 E:513 ||| NN
,  ||| S:513 E:515 ||| ,
and  ||| S:515 E:519 ||| CC
the  ||| S:519 E:523 ||| DT
indications  ||| S:523 E:535 ||| NNS
for  ||| S:535 E:539 ||| IN
POEM  ||| S:539 E:544 ||| NNP
are  ||| S:544 E:548 ||| VBP
expanding  ||| S:548 E:558 ||| VBG
to  ||| S:558 E:561 ||| TO
include  ||| S:561 E:569 ||| VB
long-standing ||| S:569 E:582 ||| JJ
,  ||| S:582 E:584 ||| ,
sigmoid  ||| S:584 E:592 ||| FW
shaped  ||| S:592 E:599 ||| FW
esophagus  ||| S:599 E:609 ||| FW
in  ||| S:609 E:612 ||| FW
achalasia ||| S:612 E:621 ||| FW
,  ||| S:621 E:623 ||| ,
even  ||| S:623 E:628 ||| RB
previously  ||| S:628 E:639 ||| RB
failed  ||| S:639 E:646 ||| VBD
endoscopic  ||| S:646 E:657 ||| JJ
treatment  ||| S:657 E:667 ||| NN
or  ||| S:667 E:670 ||| CC
surgical  ||| S:670 E:679 ||| JJ
myotomy ||| S:679 E:686 ||| NN
,  ||| S:686 E:688 ||| ,
and  ||| S:688 E:692 ||| CC
other  ||| S:692 E:698 ||| JJ
spastic  ||| S:698 E:706 ||| NNS
esophageal  ||| S:706 E:717 ||| VBP
motility  ||| S:717 E:726 ||| JJ
disorders ||| S:726 E:735 ||| NNS
.  ||| S:735 E:737 ||| .
Accumulating  ||| S:737 E:750 ||| VBG
data  ||| S:750 E:755 ||| NNS
about  ||| S:755 E:761 ||| IN
POEM  ||| S:761 E:766 ||| NNP
demonstrate  ||| S:766 E:778 ||| VBP
excellent  ||| S:778 E:788 ||| JJ
short-term  ||| S:788 E:799 ||| JJ
outcomes  ||| S:799 E:808 ||| NNS
with  ||| S:808 E:813 ||| IN
minimal  ||| S:813 E:821 ||| JJ
risk  ||| S:821 E:826 ||| NN
of  ||| S:826 E:829 ||| IN
major  ||| S:829 E:835 ||| JJ
adverse  ||| S:835 E:843 ||| JJ
events ||| S:843 E:849 ||| NNS
,  ||| S:849 E:851 ||| ,
and  ||| S:851 E:855 ||| CC
some  ||| S:855 E:860 ||| DT
existing  ||| S:860 E:869 ||| JJ
long-term  ||| S:869 E:879 ||| JJ
data  ||| S:879 E:884 ||| NNS
show  ||| S:884 E:889 ||| VBP
the  ||| S:889 E:893 ||| DT
efficacy  ||| S:893 E:902 ||| NN
of  ||| S:902 E:905 ||| IN
POEM  ||| S:905 E:910 ||| NNP
to  ||| S:910 E:913 ||| TO
be  ||| S:913 E:916 ||| VB
long  ||| S:916 E:921 ||| JJ
lasting ||| S:921 E:928 ||| NN
.  ||| S:928 E:930 ||| .
In  ||| S:930 E:933 ||| IN
this  ||| S:933 E:938 ||| DT
review  ||| S:938 E:945 ||| NN
article ||| S:945 E:952 ||| NN
,  ||| S:952 E:954 ||| ,
we  ||| S:954 E:957 ||| PRP
review  ||| S:957 E:964 ||| VB
the  ||| S:964 E:968 ||| DT
technical  ||| S:968 E:978 ||| JJ
details  ||| S:978 E:986 ||| NNS
and  ||| S:986 E:990 ||| CC
clinical  ||| S:990 E:999 ||| JJ
outcomes  ||| S:999 E:1008 ||| NNS
of  ||| S:1008 E:1011 ||| IN
POEM ||| S:1011 E:1015 ||| NNP
,  ||| S:1015 E:1017 ||| ,
and  ||| S:1017 E:1021 ||| CC
discuss  ||| S:1021 E:1029 ||| VB
some  ||| S:1029 E:1034 ||| DT
considerations  ||| S:1034 E:1049 ||| NNS
of  ||| S:1049 E:1052 ||| IN
POEM  ||| S:1052 E:1057 ||| NNP
in  ||| S:1057 E:1060 ||| IN
special  ||| S:1060 E:1068 ||| JJ
situations ||| S:1068 E:1078 ||| NNS
.  ||| S:1078 E:1080 ||| .
